A retrospective study to investigate the efficacy and safety of Rituximab in patient with severe relapsing granulomatosis with polyangiitis.
Phase of Trial: Phase IV
Latest Information Update: 05 Dec 2015
At a glance
- Drugs Rituximab (Primary)
- Indications Granulomatosis
- Focus Adverse reactions; Therapeutic Use
- 05 Dec 2015 New trial record